Anne Dompmartin Selected Research

Anne Dompmartin Research Topics

Disease

7	Wounds and Injuries (Trauma) 09/2018 - 10/2007
6	Neoplasms (Cancer) 04/2023 - 07/2012
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2024 - 09/2011
5	Melanoma (Melanoma, Malignant) 08/2023 - 01/2017
4	Pain (Aches) 09/2018 - 07/2008
3	Vascular Malformations 11/2023 - 07/2008
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2022 - 03/2014
2	Bullous Pemphigoid (Pemphigoid) 12/2019 - 01/2019
2	Skin Neoplasms (Skin Cancer) 01/2018 - 07/2012
2	Keloid 01/2014 - 09/2008
2	Cicatrix (Scar) 01/2014 - 09/2008
2	Leg Ulcer 07/2012 - 06/2008
1	Carcinoma (Carcinomatosis) 05/2024
1	Pemphigoid Gestationis (Herpes Gestationis) 06/2023
1	Blister (Bulla) 06/2023
1	Dyslipidemias (Dyslipidemia) 04/2023
1	Hemangioma (Angioma) 06/2022
1	Atopic Dermatitis (Atopic Eczema) 07/2019
1	Eosinophilia 07/2019
1	Conjunctivitis 07/2019
1	Pathologic Complete Response 01/2019
1	Necrosis 09/2018
1	Infections 09/2018
1	Burns 09/2018
1	Panniculitis 06/2018
1	Fasciitis (Fascitis) 06/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Blue rubber bleb nevus syndrome 01/2017
1	Warts (Wart) 01/2017
1	Uniparental Disomy 12/2014
1	Residual Neoplasm 03/2014
1	Mycosis Fungoides 03/2014
1	Lymphoma (Lymphomas) 03/2014
1	Pruritus (Itching) 01/2014
1	Klippel-Trenaunay-Weber Syndrome (Syndrome, Klippel-Trenaunay-Weber) 12/2011
1	Glomus vagale tumors 12/2011
1	Hypertrophic Cicatrix (Hypertrophic Scar) 09/2008
1	Hemorrhage 07/2008
1	Thrombosis (Thrombus) 07/2008

Drug/Important Bio-Agent (IBA)

3	Sirolimus (Rapamycin)FDA Link 11/2023 - 07/2012
3	Immune Checkpoint InhibitorsIBA 04/2023 - 09/2021
3	Monoclonal AntibodiesIBA 01/2023 - 09/2011
2	cemiplimabIBA 05/2024 - 01/2023
2	AntibodiesIBA 06/2023 - 01/2023
2	NivolumabIBA 04/2023 - 09/2021
2	pembrolizumabIBA 04/2023 - 09/2021
2	IpilimumabIBA 04/2023 - 09/2021
2	CytokinesIBA 12/2019 - 01/2019
2	AutoantigensIBA 12/2019 - 01/2019
2	Calcineurin InhibitorsIBA 01/2018 - 07/2012
2	Colloids (Colloid)IBA 07/2012 - 06/2008
2	OligosaccharidesIBA 07/2012 - 06/2008
1	Programmed Cell Death 1 ReceptorIBA 05/2024
1	Immunoglobulin G (IgG)IBA 06/2023
1	Propranolol (Inderal)FDA LinkGeneric 06/2022
1	mogamulizumabIBA 03/2022
1	dupilumabIBA 07/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	cerium nitrateIBA 09/2018
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2018
1	sulfadiazine silver drug combination cerous nitrateIBA 09/2018
1	MucinsIBA 06/2018
1	Ointments (Pastes)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2017
1	AntigensIBA 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	LigandsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	Sclerosing Solutions (Sclerosing Agents)IBA 12/2011
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	ErbB Receptors (EGF Receptor)IBA 09/2011
1	Cetuximab (Erbitux)FDA Link 09/2011
1	FibrinIBA 01/2010
1	PlasticsIBA 09/2008
1	fibrin fragment D (D-dimer)IBA 07/2008
1	Fibrinogen (Factor I)FDA Link 07/2008

Therapy/Procedure

5	Therapeutics 08/2023 - 07/2012
2	Radiotherapy 05/2024 - 01/2023
2	Aftercare (After-Treatment) 05/2024 - 01/2014
2	Cryosurgery 01/2014 - 09/2008
2	Debridement 04/2012 - 01/2010
1	Immunotherapy 09/2021
1	Surgical Amputation (Amputations) 09/2018
1	Ambulatory Care (Outpatient Care) 01/2018
1	Secondary Prevention 01/2018
1	Complementary Therapies (Alternative Medicine) 01/2017
1	Laser Therapy (Surgery, Laser) 01/2017
1	Traditional Medicine (Folk Remedies) 01/2017
1	Cryotherapy (Therapy, Cold) 01/2017
1	Stem Cell Transplantation 03/2014
1	Transplantation 03/2014
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2014
1	Kidney Transplantation 07/2012
1	Maggot Debridement Therapy 04/2012
1	Sclerotherapy 12/2011
1	Drug Therapy (Chemotherapy) 09/2011